COMPOUNDS FOR TREATMENT A CORONAVIRUS INFECTION

The present invention is generally directed to inhibitors of SARS-CoV-2-related 3C-like protease (Mpro) useful in the treatment of coronavirus infection and having the Formula (A): La présente invention concerne de manière générale des inhibiteurs de la protéase de type 3C (Mpro) associée au SARS-Co...

Full description

Saved in:
Bibliographic Details
Main Authors ROGOVOY, Boris, ABAGYAN, Ruben, BERISHVILI, Vladimir, ORRY, Andrew, LAM, Polo Chun-Hung, KYSIL, Volodymyr, ZAPATA, Juan Carlos, SAVCHUK, Nikolay, LI, Haishan, MORENO, Sandra Margarita Medina, PAUZA, Charles David
Format Patent
LanguageEnglish
French
Published 21.12.2023
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:The present invention is generally directed to inhibitors of SARS-CoV-2-related 3C-like protease (Mpro) useful in the treatment of coronavirus infection and having the Formula (A): La présente invention concerne de manière générale des inhibiteurs de la protéase de type 3C (Mpro) associée au SARS-CoV-2 utiles dans le traitement d'une infection à coronavirus et ayant la formule (A).
Bibliography:Application Number: WO2023US68573